Browse Category

Business News News 11 January 2026

Kweichow Moutai Class A stock eyes Monday open as iMaotai adds 2.7 mln users and zodiac bottles sell out

Kweichow Moutai Class A stock eyes Monday open as iMaotai adds 2.7 mln users and zodiac bottles sell out

Shanghai, Jan 12, 2026, 03:30 (GMT+8) — Premarket Kweichow Moutai’s drive to boost sales via its iMaotai app will catch attention at Monday’s open after chairman Chen Hua revealed the platform gained over 2.7 million new users in just nine days. “Most of the users reached by iMaotai are not core customers from existing channels, but real consumers previously hard to reach,” Chen said, according to a report referencing the group’s official WeChat account. (Futu News) This matters now as the company is counting on holiday releases and tighter sales channel control ahead of Lunar New Year, when demand for
11 January 2026
Novartis stock on watch as Florida radioligand plant plan tees up JPM conference week

Novartis stock on watch as Florida radioligand plant plan tees up JPM conference week

New York, January 11, 2026, 14:15 EST — Market closed. Novartis AG’s U.S.-listed shares (NVS) closed Friday mostly flat. Still, the stock starts the new week with a notable development: the company announced a new U.S. manufacturing facility for its radioligand cancer therapies. (Novartis) The timing matters because radioligand therapy demands tight logistics — every dose is tailored to a single patient, and the clock is ticking the moment it’s prepared. More capacity and smarter location choices mean fewer missed or delayed treatments. Novartis has been pushing that point hard, and investors are taking note. (Novartis) The timing coincides with
Meta’s nuclear power deals jolt data center stocks as CPI week looms

Meta’s nuclear power deals jolt data center stocks as CPI week looms

New York, January 11, 2026, 12:57 EST — Market closed Data center-related stocks open Monday with attention on power supply following Meta’s fresh nuclear energy agreements to support its AI expansion. Vistra jumped roughly 10.5% on Friday, Oklo climbed about 7.9%, and Meta edged up around 1.1%. Here’s why it’s crucial today: the market now sees electricity as a hard limit, not just an afterthought, for the upcoming surge in AI data centers. This shift has dragged utilities and nuclear developers into the mix, alongside the chipmakers and server firms that have traditionally led this trade. Spending buzzed again Friday.
Polestar stock falls after record 2025 sales; Feb. 18 strategy update becomes the next test

Polestar stock falls after record 2025 sales; Feb. 18 strategy update becomes the next test

New York, January 11, 2026, 12:45 EST — Market closed Polestar shares dropped roughly 5.5% to $20.99 in the final U.S. session, following the Swedish EV maker’s quarterly retail sales surge. The company also announced a strategy update scheduled for Feb. 18, which will feature a financial outlook. The company’s sales update is crucial as Polestar pushes to prove it can grow without relying on fresh capital. With U.S. markets closed for the weekend, the key will be whether Monday triggers more selling or sparks some bargain hunting. The environment looks tough. Stellantis announced it will drop plug-in hybrid programs
LVMH stock ends week higher as champagne strike threat looms — what to watch Monday

LVMH stock ends week higher as champagne strike threat looms — what to watch Monday

Paris, January 11, 2026, 17:14 CET — The market has closed. LVMH Moet Hennessy Louis Vuitton SE shares enter the new week amid mounting labour tensions, as a union has urged additional strike action within the group’s wines and spirits division, targeting its champagne houses. Why this matters now: after a broad rally in European equities, investors are once again reacting sharply to any disruption risks in luxury stocks, with LVMH remaining the sector’s key bellwether in Paris. The timing hits hard since the dispute revolves around pay and benefits at Moët Hennessy amid softer sales. It’s a clear sign
Johnson & Johnson stock in focus: Trump drug-price pact and fresh cancer data before Monday

Johnson & Johnson stock in focus: Trump drug-price pact and fresh cancer data before Monday

New York, Jan 11, 2026, 10:45 EST — Market closed. Shares of Johnson & Johnson (JNJ.N) dipped 0.7% on Friday to $204.39 following the company’s announcement of a deal with the Trump administration to lower U.S. drug prices. In return, J&J secured exemptions from certain U.S. tariffs. The company said it will offer medicines at discounted rates via TrumpRx.gov and match Medicaid pricing levels seen in other developed countries, though it did not specify which drugs would be involved or the exact discount sizes. The administration made similar deals with nine other pharmaceutical firms in December as part of its
Eli Lilly stock (LLY) slips into JPM Week as Amazon adds rival Wegovy pill — what to watch next

Eli Lilly stock (LLY) slips into JPM Week as Amazon adds rival Wegovy pill — what to watch next

New York, Jan 11, 2026, 10:13 EST — Market closed Eli Lilly and Company shares dropped 1.99% on Friday, closing at $1,063.56. The stock heads into Monday’s session under pressure after a volatile week for major pharmaceutical firms. Investors are closely eyeing signs of a pricing battle in the obesity-drug sector after Amazon Pharmacy announced it now stocks Novo Nordisk’s Wegovy pill, available both through insurance and a cash-pay plan starting at $149 a month. Amazon added that eligible customers with commercial insurance might pay as little as $25 for a single month’s supply. The timing is key as the
Azul S.A. Sponsored ADR Pfd (AZULQ) in focus as board tweaks debt conversion ahead of Jan. 12 vote

Azul S.A. Sponsored ADR Pfd (AZULQ) in focus as board tweaks debt conversion ahead of Jan. 12 vote

New York, January 11, 2026, 09:32 EST — Market closed Azul S.A.’s sponsored preferred ADRs are being closely watched ahead of Monday after the Brazilian airline released board minutes clarifying the terms for a mandatory debenture conversion linked to its Chapter 11 plan in the U.S. The minutes specify a swap ratio of 1,498,422 preferred shares per debenture, contingent on the publication of a confirmation order. Timing is tied to the completion of a Brazilian share offering and associated subscription warrants. Azul also confirmed that debenture interest will be “forgiven and definitively extinguished” upon settlement, with 908,401 debentures converting into
BigBear.ai stock (BBAI) eyes Monday open after Kraft Group, Patriots tie-up; share vote looms

BigBear.ai stock (BBAI) eyes Monday open after Kraft Group, Patriots tie-up; share vote looms

NEW YORK, Jan 11, 2026, 06:10 EST — Market has closed. Shares of BigBear.ai Holdings, Inc edged up roughly 0.6% to $6.20 on Friday, moving in a range between $6.15 and $6.50. Investors reacted to the announcement of a new commercial deal involving the Kraft Group and the New England Patriots. U.S. markets are closed for the weekend, leaving Monday to reveal if the sports-and-supply-chain story has staying power or if it’s just another rapid move in a small-cap stock prone to quick shifts on minor news. The deal is important now as BigBear.ai pushes to expand past its core
Haleon PLC stock: HLN slips on India leadership move as earnings loom

Haleon PLC stock: HLN slips on India leadership move as earnings loom

London, Jan 11, 2026, 09:53 GMT — Market closed Haleon PLC shares slipped 1.2% to 367.5 pence on Friday after the consumer health group named Kedar Lele to lead its India Subcontinent operations and join its senior leadership. (MarketScreener) The reason this matters now is straightforward. India’s market for everyday health brands moves quickly, shifting based on distribution, pricing discipline, and the intensity of new product launches. This lull in company news is typical. With earnings still weeks off, investors zero in on management changes, hunting for clues about future focus and spending. Haleon’s leadership team lists Lele as a
GSK stock in focus as Jemperli royalty fight escalates ahead of JPM conference

GSK stock in focus as Jemperli royalty fight escalates ahead of JPM conference

London, Jan 11, 2026, 08:35 GMT — The market has closed. Shares of GSK plc face fresh legal uncertainty on Monday after AnaptysBio moved to dismiss part of a contract claim related to royalties for the cancer drug Jemperli. On Friday, GSK slipped 0.26% to 1,886 pence, just shy of its 52-week peak at 1,909.5. Technical traders are eyeing the 1,830 pence level, close to the 200-day moving average, as a key support zone. Why it matters now: the royalty dispute comes at a critical moment, with healthcare investors bracing for a busy news week in San Francisco and GSK’s
Diageo stock (DGE.L) in focus after Kenya court delays $2.3 billion EABL sale to Asahi

Diageo stock (DGE.L) in focus after Kenya court delays $2.3 billion EABL sale to Asahi

London, Jan 11, 2026, 08:08 GMT — The market has closed. Diageo’s London-listed shares face uncertainty on Monday as a Kenyan court delays a hearing tied to its $2.3 billion asset sale. Kenya’s High Court moved the hearing to Jan. 20, aiming to block the deal. Judge Bahati Mwamuye ruled that while the parties may proceed with preliminary actions like seeking regulatory approvals, they cannot close the transaction before that date. Despite the delay, those involved still anticipate completing the deal in the second half of the year. The case was brought by Kenyan beer distributor Bia Tosha, linked to
1 34 35 36 37 38 89

Stock Market Today

Macquarie Group share price slips 2% after APRA eases liquidity curbs — what to watch next week

Macquarie Group share price slips 2% after APRA eases liquidity curbs — what to watch next week

7 February 2026
Macquarie Group shares fell 2.17% to A$207.83 Friday, marking a third straight decline as the ASX 200 slid 2%. Australia’s regulator trimmed liquidity requirements for Macquarie Bank after improvements in controls. Macquarie Asset Management announced two UK utility deals, including full ownership of Last Mile Infrastructure and the purchase of Energy Assets Group. Investors await Tuesday’s operational briefing.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 07.02.2026

7 February 2026
LIVEMarkets rolling coverageStarted: February 7, 2026, 12:00 AM ESTUpdated: February 7, 2026, 1:07 AM EST Crude Oil Prices Rise on Dollar Weakness, Geopolitical Tensions February 7, 2026, 12:52 AM EST. Crude oil prices edged higher on Friday, supported by a weaker U.S. dollar and escalating geopolitical risks in the Middle East. March WTI crude gained 0.41%, rebounding from early losses, while gasoline prices rose 1.38%. Doubts over a U.S.-Iran nuclear deal loom after reports of Iran's refusal to halt uranium enrichment, raising the risk of military action and potential disruption of vital shipping routes. Additionally, a surge in U.S. consumer
Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week

Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week

7 February 2026
Seagate shares rose 5.9% to $429.32 Friday after Citigroup raised its price target to $480 and reiterated a buy rating. The gain ended a two-day slide but left the stock 6.6% below its Feb. 3 high. CEO Dave Mosley sold 20,000 shares on Feb. 2 under a pre-arranged plan, SEC filings show. U.S. jobs and inflation data next week are seen as key tests for tech stocks.
Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

7 February 2026
Cummins shares jumped 6.8% to $577.73 Friday, recovering from a nearly 9% post-earnings drop the day before. The company reported Q4 revenue up 1% to $8.54 billion, took a $218 million charge tied to its hydrogen business, and guided for 2026 EBITDA of 17–18% of sales. Demand for data center generators offset weakness in North American truck markets. Analyst reaction was mixed; Truist raised its price target.
Go toTop